Trial reportJournal of substance abuse treatment2021
Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health.
Trial report in Journal of substance abuse treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- User Engagement With mHealth Interventions to Promote Treatment Adherence and Self-Management in People With Chronic Health Conditions: Systematic Review.Journal of medical Internet research · 2024Pooled it
- A systematic review of remotely delivered contingency management treatment for substance use.Journal of substance use and addiction treatment · 2023Pooled it
- Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial.The American journal of drug and alcohol abuse · 2024Trial
- A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth.Drug and alcohol dependence · 2022Trial
- Preferences for Smartphone Versus In-Person Delivery of Contingency Management: A Web-Based Survey of Australians Who Use Methamphetamine.Drug and alcohol review · 2026Article
- Innovations in health behavior research: Current status and strategic future directions.Experimental and clinical psychopharmacology · 2026Review
- Smartphone-Based Contingency Management for Patients Who Use Methamphetamine: Qualitative Analysis of Patient and Clinician Perspectives.JMIR formative research · 2026Article
- Digital Contingency Management for Substance Use Disorder Treatment: 12-Month Quasi-Experimental Design.JMIR mental health · 2025Article
- Current approaches using remote monitoring technology in alcohol use disorder (AUD): an integrative review.Alcohol and alcoholism (Oxford, Oxfordshire) · 2025Review
- Using the IFASIS (Inventory of Factors Affecting Successful Implementation and Sustainment) to advance context-specific and generalizable knowledge of implementation determinants: case study of a digital contingency management platform.Implementation science communications · 2025Article
- Mobile telephone contingency management to encourage adherence to supervised medication among individuals most at risk of non-adherence to opioid agonist treatment: a study protocol for a feasibility study (TIES2).Pilot and feasibility studies · 2025Article
- Article
- Digitally delivered contingency management during methadone treatment for people with co-occurring cocaine and opioid use: a protocol for a randomized controlled trial.Frontiers in psychiatry · 2025Article
- Digitally-enhanced medication-assisted treatment for opioid use disorder: acceptability, engagement and treatment retention.Frontiers in psychiatry · 2025Article
- Managing Stimulant Use Among People With HIV: Harm-Reduction Strategies From Behavior to Medication.Topics in antiviral medicine · 2024Review
- Smartphone App-Based Contingency Management and Opioid Use Disorder Treatment Outcomes.JAMA network open · 2024Article
- Article
- Therapeutic Content of Mobile Phone Applications for Substance Use Disorders: An Umbrella Review.Mayo Clinic proceedings. Digital health · 2024Article
- Contingency Management for Drug Use Disorders: Meta-Analysis and Application of Tolin's Criteria.Clinical psychology : a publication of the Division of Clinical Psychology of the American Psychological Association · 2024Article
- Additive effects of adjunctive app-based interventions for mental disorders - A systematic review and meta-analysis of randomised controlled trials.Internet interventions · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Digital health tools can provide convenient delivery of evidence-based treatments. The DynamiCare Health smartphone app delivers a contingency management intervention for substance use disorder consisting of remote self-testing for alcohol (breath) and drugs (saliva) with remote test validation and delivery of financial incentives for negative test results. This study examined feasibility, engagement (duration and consistency of app utilization), and impact on usual care treatment participation when a community substance use treatment program implemented this digital therapy among its patients. The study randomly assigned patients with alcohol use disorder (N = 61) to receive either DynamiCare along with treatment-as-usual (TAU; N = 29) or TAU only (N = 32) during a 90-day evaluation period. Mean duration between first and last app use was 64 (±35) days, with mean earnings of $248 (±$209, out of $600 maximum). Among those with any app use (n = 25), compliance was 68% and 74%, respectively for requested breath and saliva samples. Overall, two thirds of patients (66%) assigned to the app used it for at least 57 days and with high rates of self-testing compliance. Those completing the assessment (n = 13; 45% of sample) endorsed high satisfaction ratings. DynamiCare versus TAU participants were more likely to be retained in usual care treatment at 90 days (24% vs 3%; (χ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.